NCT03770923RecruitingPhase 3
Effect of Some Drugs on Rheumatoid Arithritis Activity
Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Antagonist on Patients With Rheumatoid Arithritis
Source: ClinicalTrials.gov · Last updated 10 Dec 2018 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Effect of Some Drugs on Rheumatoid Arithritis Activity.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- First submitted
- 7 Dec 2018
- Start date
- 1 Oct 2018
- Primary completion date
- Oct 2026
- Lead sponsor
- Sherief Abd-Elsalam
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT03770923
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 75
- From 1 Oct 2018 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- liver or renal disease
Who the study is looking for
- Rheumatoid arthritis
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sherief Abd-Elsalam Coordinator of this site? Confirm its status | Tanta | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.